About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Vitamine D in Multiple Sclerosis

NCT01768039·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Mahmoud Abedini, MD
CONTACT
01513243158 mahmoudabedini@yahoo.com

Lead

Mazandaran University of Medical Sciences

Age

18–50

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

BMI:18-30kg/m2
caucasian race
Relapsing remitting multiple sclerosis
treatment with interferon beta

You may not be if

Recent vitamin D supplement therapy
Restricted fat diet
nephrolithiasis in recent 5 years
Past history of hyperparathyroidism, sarcoidosis, cancer
Past history of hepatic disease
Past history of gastrointestinal disease
Past history of mycobacterial infection
Past history of hypercalcemia and hypercalciuria
serum creatinine\>1.5
Smoking, drug abuse and corticosteroid therapy in recent year
treatment with thiazides or other drugs that inhibit vitamin D absorption
Disease attack in recent 2 months
Serum Ca\>2.6mm0l/L
Serum 25(OH)D\>85mmol/L
hypersensitivity to cholecalciferol
Past history of heart disease
Major depression
Uncontrolled hypertension (BP\>180/110)
Immunosuppressive therapy

The record

StatusUnknown

PhasePhase 3

Taking part240

StartedMar 2013

UpdatedJan 15, 2013

Conditions

Multiple Sclerosis

Where1

Mazandaran University of medical sciences
Sari, Mazandaran, Iran

Clareo Health | Vitamine D in Multiple Sclerosis